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Around 4 % of the population suffer from IgE-mediated
food allergies in Western countries and the number of
food-allergenic people is increasing. Individuals with
certain pollen allergies may also suffer from a sensitisa-
tion to proteins in the foods. As an example a person
sensitised to the major birch pollen allergen, Bet v 1, is
often sensitised to its homologues, such as the major
allergens of apple, Mal d 1, and celery, Api g 1, as well.
Development of diagnostic tools for the reliable, sensi-
tive and quick detection of allergens present in various
food products are essential for allergic persons to pre-
vent the consumption of substances causing mild and
even life-threatening immune responses. Traditionally
the diagnostics of allergens are based on the use of
human IgE serum pools isolated from allergic patients.
The use of monoclonal antibodies would ensure the spe-
cific detection of the harmful food content for a sensi-
tised person.
The production of functional antibody fragments and
their efficient display on the filamentous phage have
made it possible to construct large and diverse antibody
phage display libraries for the isolation of recombinant
antibodies. Aim of the study was to construct mouse IgG
antibody libraries from immunised mice. The selection of
the resulting libraries was carried out using recombinant
allergens, rMal d 1 and rApi g 1 which were produced as
soluble non-fusion proteins in bacterial cells and purified
by a conventional chromatography. The binding proper-
ties of the isolated Fab fragments towards the recombi-
nant allergens and native allergens from natural sources
were characterised. Interestingly, isolated Mal d 1 -speci-
fic antibody bound also to Bet v 1, the main allergen eli-
citing the cross-reactivity syndrome between the birch
pollen and apple. Despite the similarities in protein ter-
tiary structure, there was no observable cross-reactivity
between Api g 1 -specific antibodies and Bet v 1 in this
study. Isolated allergen-specific antibodies can be utilised
as diagnostic and research tools for the specific and reli-
able detection of allergens from different consumable
products as well as studying allergy-antibody interactions.
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